- Home
- RIGL vs NOVA Comparison
RIGL vs NOVA Comparison
Compare RIGL & NOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- NOVA
- Stock Information
- Founded
- RIGL 1996
- NOVA 2012
- Country
- RIGL United States
- NOVA United States
- Employees
- RIGL N/A
- NOVA N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- NOVA Power Generation
- Sector
- RIGL Health Care
- NOVA Utilities
- Exchange
- RIGL Nasdaq
- NOVA Nasdaq
- Market Cap
- RIGL 486.4M
- NOVA 532.3M
- IPO Year
- RIGL 2000
- NOVA 2019
- Fundamental
- Price
- RIGL $20.99
- NOVA $2.45
- Analyst Decision
- RIGL Buy
- NOVA Buy
- Analyst Count
- RIGL 5
- NOVA 23
- Target Price
- RIGL $34.80
- NOVA $9.86
- AVG Volume (30 Days)
- RIGL 216.6K
- NOVA 9.8M
- Earning Date
- RIGL 03-04-2025
- NOVA 02-19-2025
- Dividend Yield
- RIGL N/A
- NOVA N/A
- EPS Growth
- RIGL N/A
- NOVA N/A
- EPS
- RIGL 0.22
- NOVA N/A
- Revenue
- RIGL $157,374,000.00
- NOVA $809,977,000.00
- Revenue This Year
- RIGL $51.34
- NOVA $19.97
- Revenue Next Year
- RIGL $15.75
- NOVA $24.22
- P/E Ratio
- RIGL $94.25
- NOVA N/A
- Revenue Growth
- RIGL 21.65
- NOVA 12.18
- 52 Week Low
- RIGL $7.48
- NOVA $2.30
- 52 Week High
- RIGL $29.82
- NOVA $13.00
- Technical
- Relative Strength Index (RSI)
- RIGL 55.77
- NOVA 32.08
- Support Level
- RIGL $20.98
- NOVA $2.30
- Resistance Level
- RIGL $23.01
- NOVA $3.38
- Average True Range (ATR)
- RIGL 1.40
- NOVA 0.32
- MACD
- RIGL 0.31
- NOVA -0.05
- Stochastic Oscillator
- RIGL 70.13
- NOVA 11.07
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About NOVA Sunnova Energy International Inc.
Sunnova Energy International Inc is a residential solar and energy storage service provider company. It offers services such as operations and maintenance, monitoring, repairs and replacements, equipment upgrades, and onsite power optimization. The products and services offered by the group include Add-on battery storage, Home solar protection plans, New solar battery storage, and various other solar systems. It operates in a single reportable segment: solar energy products and services.